Pa Shun International Holdings Limited (0574) AI Stock Analysis

• Market Cap: HK$84.07M
• Dividend Yield: N/A
• Average Volume (3M): 1.15M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.24
• Revenue Growth: -9.71%
• EPS Growth: -279.92%
• Country: HK
• Employees: 97
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Pharmaceuticals
• EPS (TTM): >-0.01
• Shares Outstanding: 1,474,992,900
• 10 Day Avg. Volume: 798,200
• 30 Day Avg. Volume: 1,152,533
• PEG Ratio: <0.01
• Price to Book (P/B): -0.48
• Price to Sales (P/S): 0.75
• P/FCF Ratio: -36.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: HK$0.05 ▲(6.00% Upside)

The score is primarily weighed down by weak financial performance (declining revenue, ongoing losses, negative equity, and negative free cash flow). Technicals provide some near-term support (price above moving averages and positive MACD) but are tempered by an overbought RSI. Valuation remains unattractive/unclear due to negative earnings and no dividend yield data.

Positive Factors

Diversified business model and revenue streams

Multiple revenue channels including direct retail sales, bulk distributor orders and private‑label contracts reduce single‑customer concentration and smooth demand cycles. Durable B2B manufacturing contracts can provide steadier order visibility and support recovery over the next 2–6 months.

Product development and supply‑chain expertise

Established capabilities in product design and supply‑chain management are structural advantages: they lower unit costs, accelerate new product introductions, and support private‑label partnerships. These operational strengths help defend margins and scale distribution over the medium term.

International distribution and strategic partnerships

A global distribution footprint and logistics/supplier partnerships expand addressable markets and reduce dependence on a single geography. Durable network effects from partner relationships improve resilience to local shocks and support revenue recovery and margin stabilization over months.

Negative Factors

Negative shareholders’ equity and solvency risk

Negative equity is a structural red flag that constrains access to traditional financing, triggers covenant risks, and limits strategic flexibility. Absent material recapitalization, this condition elevates default and restructuring risk over the medium term and impairs long‑term investment capacity.

Consistently negative free cash flow

Persistent negative FCF indicates operations do not generate sufficient cash to fund capex, working capital or debt service, forcing reliance on external funding. Over 2–6 months this erodes financial flexibility, raises refinancing risk, and can constrain strategic initiatives or supplier relationships.

Multi‑year revenue decline and persistent losses

Extended top‑line contraction combined with negative margins signals weakening competitive position and operating inefficiency. Without sustainable revenue stabilization or margin improvement, the company faces structural challenges to restore profitability and rebuild balance‑sheet strength over the medium term.

Pa Shun International Holdings Limited Business Overview & Revenue Model

Company Description

Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution activities in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Self-Operated Retail Pharmacies, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution segment sells pharmaceutical products to wholesalers, franchise retail pharmacy chain stores, and hospitals and other medical institutions in rural areas. The Self-Operated Retail Pharmacies segment engages in the sale of pharmaceutical and healthcare products, cosmetic products, and daily necessities in self-operated retail pharmacies. The Pharmaceutical Manufacturing segment sells pharmaceutical products manufactured by the company. The company was formerly known as Pa Shun Pharmaceutical International Holdings Limited and changed its name to Pa Shun International Holdings Limited in June 2017. The company was incorporated in 2011 and is based in San Po Kong, Hong Kong. Pa Shun International Holdings Limited is a subsidiary of Praise Treasure Limited.

How the Company Makes Money

Pa Shun International Holdings Limited generates revenue through multiple streams, primarily from the sale of its manufactured consumer goods, including electronics and home appliances. The company operates on a business model that involves designing, producing, and distributing these products to various retailers and wholesalers both domestically and internationally. Key revenue streams include direct sales to retailers, bulk orders from distributors, and partnerships with international brands for private label manufacturing. Additionally, the company may benefit from value-added services such as after-sales support and warranty services, enhancing customer loyalty and driving repeat business. Strategic partnerships with suppliers and logistics companies also play a crucial role in optimizing operational efficiency and cost management, further contributing to its profitability.

Pa Shun International Holdings Limited Financial Statement Overview

Summary

Financial statements indicate severe weakness: multi-year revenue decline, persistent negative profitability (negative net/EBIT/EBITDA margins), negative shareholders’ equity signaling elevated solvency risk, and consistently negative free cash flow showing poor cash sustainability.

Income Statement

The company has experienced significant revenue decline over the years, with a notable drop from 2019 to 2024. Gross profit margins have been volatile, and the net profit margin has been negative in recent years, indicating ongoing losses. The EBIT and EBITDA margins are also negative, reflecting operational inefficiencies and financial challenges.

Balance Sheet

The balance sheet shows a concerning financial position with negative stockholders' equity, indicating potential insolvency risks. The debt-to-equity ratio cannot be calculated due to negative equity, but high total liabilities relative to assets suggest significant leverage. The equity ratio is negative, further highlighting financial instability.

Cash Flow

The company has consistently reported negative free cash flow, indicating cash outflows exceed inflows from operations. The operating cash flow to net income ratio is negative, reflecting poor cash generation relative to net losses. The free cash flow to net income ratio is also negative, underscoring cash flow challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	86.42M	86.55M	129.43M	71.78M	85.91M	474.83M
Gross Profit	13.74M	17.06M	29.43M	13.30M	11.06M	17.70M
EBITDA	99.00K	2.89M	19.65M	-3.26M	-11.85M	-11.10M
Net Income	-59.80M	-15.31M	2.35M	-43.38M	-330.40M	-419.19M
Balance Sheet
Total Assets	161.96M	179.65M	206.57M	136.09M	468.59M	503.19M
Cash, Cash Equivalents and Short-Term Investments	3.56M	15.97M	16.51M	1.90M	2.27M	5.26M
Total Debt	40.42M	44.03M	165.97M	108.71M	99.01M	102.71M
Total Liabilities	310.43M	315.68M	322.67M	251.60M	251.59M	225.20M
Stockholders Equity	-148.47M	-136.04M	-116.10M	-115.52M	-58.50M	277.98M
Cash Flow
Free Cash Flow	5.39M	-1.77M	-35.00M	-2.35M	-22.12M	-6.59M
Operating Cash Flow	5.49M	-1.68M	-34.93M	-2.32M	-21.89M	-6.51M
Investing Cash Flow	-596.00K	-88.00K	-65.00K	2.98M	24.97M	-2.43M
Financing Cash Flow	-5.96M	1.23M	49.61M	-1.02M	-6.07M	3.17M

Pa Shun International Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.05
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0574, the sentiment is Positive. The current price of 0.05 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.04, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 77.35 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0574.

Pa Shun International Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8307	58 Neutral	HK$79.35M	-60.61	-19.93%	―	-2.91%	55.41%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
0401	51 Neutral	HK$72.83M	-8.50	-11.91%	―	-4.50%	75.98%
0911	47 Neutral	HK$44.06M	-4.65	-2.40%	―	-40.37%	-112.64%
0574	44 Neutral	HK$84.07M	-1.30	―	―	-9.71%	-279.92%